However, in August 2024, the World Health Organization suggested that semaglutide, but not liraglutide, may be associated with suicide and self-injury based on an analysis of individual case safety reports from its postmarketing surveillance database
[1] Weight loss achieved through Wegovy can influence thyroid hormone requirements
In 2024 Blue Cross Blue Shield of Michigan informed members and physicians about a change in coverage for GLP-1s.On the surface, GLP-1s promise weight loss, lower blood pressure and a reduced risk of heart and kidney disease, according to the Cleveland Clinic
In short, it is one of the building blocks that keeps your body running
As patents expire, this creates opportunities for various companies to manufacture cheaper biosimilars, resulting in intense competition, thus significantly lowering the cost of treatment
What is Melanotan-II the drug that the TGA urges consumers to avoid? UNSW Newsroom, 30 January 2023, Accessed 18 April 2023